Vencora is a leading global acquirer of software businesses that collectively transform the financial services market. Our companies are stronger together. By sharing resources and best practices, all of our companies are well-positioned to expand and grow. Leverage the market geography of our companies to reach new customers, capitalize on trends, and expand your capabilities. We are invested in your success. Our companies share a common ecosystem. Each business operates independently with communal access to sales networks, product growth, and specialized professional support.
| Website | http://vencora.com |
| Revenue | $22.4 million |
| Employees | 56 (46 on RocketReach) |
| Industry | Software Development |
| Keywords | Financial Services, Financial Technology, Fintech, Market Transformation, Digital Finance, Software, Innovation, Collaboration, Technology, Market Leader, Best Practices, Strategic Partnerships, Network, Investment, Scalability, Resource Sharing, Portfolio, Business, Growth, Payments |
| Competitors | Amgen, Takeda, Moderna Therapeutics, Novavax, CureVac, Zymeworks Inc., INOVIO Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., NantKwest, Genocea +42 more (view full list) |
Looking for a particular Vencora employee's phone or email?
The Vencora annual revenue was $22.4 million in 2026.
Kevin Bradley is the CEO of Vencora.
46 people are employed at Vencora.